Daria Harlin-Schuman

Daria Harlin-Schuman

Director, Reimbursement & Market Access
Background

Ms. Schuman assists clients in understanding the health plan coverage and reimbursement process during clinical research. She provides Medicare predetermination assistance for clients participating in clinical research and also prepares reimbursement resources to facilitate site education on compliant billing practices. 

Ms. Schuman contributes to the research and analysis of clinical literature to be incorporated into Reimbursement Landscape Assessments, Strategic Reimbursement Planning and recommendations to orthopedic and cardiovascular medical device companies. She is responsible for the detailed review and syntheses of CMS-issued proposed and final rules, with an eye towards how companies might be affected by newly implemented regulations. 

Education

Ms. Schuman received her Bachelor of Art in Pyschology from Boston University and her degree in law from American University Washington College of Law.

Experience

Ms. Schuman has 7 years of experience relating to health economics, reimbursement, and public policy. She facilitates the process of clinical trial agreement and budget development and negotiation between sponsor medical device companies and clinical trial sites, ensuring compliance with CMS, FDA, and GCP regulations and guidelines. 

Overview

Ms. Schuman is responsible for overseeing the development and negotiation of clinical trial agreements and related budgets on behalf of study sponsors running clinical research managed by MCRA's Clinical Research Organization. Prior to joining MCRA in August 2010, Ms. Schuman worked at a small securities litigation firm as well as a special education law firm where she conducted research and drafted briefs in preparation for due process hearings on behalf of disabled students and their families. Ms. Schuman also has a policy background, having worked at a non-profit where she managed project finances and researched/produced policy memoranda. 

Get in Touch